Optimization of polyene-azole combination therapy against aspergillosis using an in vitro pharmacokinetic-pharmacodynamic model.
Siopi, Maria; Siafakas, Nikolaos; Vourli, Sophia; Zerva, Loukia; Meletiadis, Joseph.
Antimicrob Agents Chemother
; 59(7): 3973-83, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25896699
Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis.
Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report.
Diagnosis and management of aspergillosis in the Netherlands: a national survey.
Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study.
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
Emergence of Azole Resistance in Aspergillus.
Impact of empirical treatment with antifungal agents on survival of patients with candidemia
Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis.
Pharmacodynamics of Voriconazole for Invasive Pulmonary Scedosporiosis.
Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels.